Skip to main content
Tuesday
December 03, 2024
Sign In
Subscribe
Home
Epaper
Economy
Aviation
Banking
Bazaar
Budget
Industry
NBR
RMG
Corporates
Stocks
Analysis
Videos
Podcast
World+Biz
Features
Book Review
Brands
Earth
Explorer
Food
Habitat
In Focus
Luxury
Mode
Panorama
Pursuit
Wheels
Subscribe
Epaper
GOVT. Ad
More
Sports
TBS Graduates
Thoughts
Splash
Bangladesh
Supplement
Infograph
Archive
Gallery
Long Read
Interviews
Offbeat
Tech
Magazine
Climate Change
Health
Cartoons
বাংলা
TUESDAY,
DECEMBER 03, 2024
Novartis
Corporates
Novartis donates Tk 5.3 million to Red Crescent for flood rehabilitation efforts
Health
Ample awareness needed at all levels to increase Biologic use: Experts
Coronavirus chronicle
Novartis working on pan-coronavirus oral treatment, CEO says
Global Economy
Novartis may divest generic unit Sandoz as price pressures mount
Coronavirus chronicle
Swiss drugmaker Novartis to help make Pfizer-Biontech Covid-19 vaccine
Global Economy
Novartis trims sales outlook after hit from Covid disruptions
Coronavirus chronicle
Novartis to provide 'no profit' Covid-19 drugs to low income countries
World+Biz
Novartis faces key meeting in US bribery scandal after settling corruption case
Coronavirus chronicle
Novartis halts malaria drug trial against Covid-19 amid participant shortfall
Covid-19 in Bangladesh
Novartis donates safety gears to combat coronavirus
Coronavirus chronicle
Novartis inks deal to make Mass General Brigham's Covid-19 vaccine candidate
Coronavirus chronicle
Novartis, US regulators agree to malaria drug trial against Covid-19
Coronavirus chronicle
Malaria drug is biggest hope against coronavirus: Novartis CEO
Show More